Back to Search Start Over

Restorative functions of Autologous Stem Leydig Cell transplantation in a Testosterone-deficient non-human primate model.

Authors :
Xia K
Chen H
Wang J
Feng X
Gao Y
Wang Y
Deng R
Wu C
Luo P
Zhang M
Wang C
Zhang Y
Zhang Y
Liu G
Tu X
Sun X
Li W
Ke Q
Deng C
Xiang AP
Source :
Theranostics [Theranostics] 2020 Jul 09; Vol. 10 (19), pp. 8705-8720. Date of Electronic Publication: 2020 Jul 09 (Print Publication: 2020).
Publication Year :
2020

Abstract

Rationale: Stem Leydig cells (SLCs) transplantation can restore testosterone production in rodent models and is thus a potential solution for treating testosterone deficiency (TD). However, it remains unknown whether these favorable effects will be reproduced in more clinically relevant large-animal models. Therefore, we assessed the feasibility, safety and efficacy of autologous SLCs transplantation in a testosterone-deficient non-human primate (NHP) model. Methods: Cynomolgus monkey SLCs (CM-SLCs) were isolated from testis biopsies of elderly (> 19 years) cynomolgus monkeys by flow cytometry. Autologous CM-SLCs were injected into the testicular interstitium of 7 monkeys. Another 4 monkeys were injected the same way with cynomolgus monkey dermal fibroblasts (CM-DFs) as controls. The animals were then examined for sex hormones, semen, body composition, grip strength, and exercise activity. Results: We first isolated CD271 <superscript>+</superscript> CM-SLCs which were confirmed to expand continuously and show potential to differentiate into testosterone-producing Leydig cells (LCs) in vitro . Compared with CM-DFs transplantation, engraftment of autologous CM-SLCs into elderly monkeys could significantly increase the serum testosterone level in a physiological pattern for 8 weeks, without any need for immunosuppression. Importantly, CM-SLCs transplantation recovered spermatogenesis and ameliorated TD-related symptoms, such as those related to body fat mass, lean mass, bone mineral density, strength and exercise capacity. Conclusion: For the first time, our short-term observations demonstrated that autologous SLCs can increase testosterone levels and ameliorate relevant TD symptoms in primate models. A larger cohort with long-term follow-up will be required to assess the translational potential of autologous SLCs for TD therapy.<br />Competing Interests: Competing Interests: The authors have declared that no competing interest exists.<br /> (© The author(s).)

Details

Language :
English
ISSN :
1838-7640
Volume :
10
Issue :
19
Database :
MEDLINE
Journal :
Theranostics
Publication Type :
Academic Journal
Accession number :
32754273
Full Text :
https://doi.org/10.7150/thno.46854